2019-08 FDA approves use of lefamulin to treat community-acquired pneumonia
Antibiotic-resistant Streptococcus pneumoniaeLefamulin
2019 Was a Year for Advancements in Infectious Diseasehttps://www.pharmacytimes.com/publications/issue/2019/December2019/2019-was-a-year-for-advancements-in-infectious-disease
LefamulinPretomanid
Changes in Therapy Recommendations in the 2019 ATS/IDSA Guidelines for Community-Acquired Pneumoniahttps://www.contagionlive.com/news/changes-in-therapy-recommendations-in-the-2019-atsidsa-guidelines-for-communityacquired-pneumonia
AmoxicillinCeftarolineCefuroximeLefamulinOmadacyclineSulbactam
FDA approves new antibiotic to treat community-acquired bacterial pneumonia | FDAhttps://www.fda.gov/news-events/press-announcements/fda-approves-new-antibiotic-treat-community-acquired-bacterial-pneumonia
2019-08 FDA approves use of lefamulin to treat community-acquired pneumoniaLefamulin
IDWeek 2019 News Network: Areas of Improvement for CAP Guidelineshttps://www.contagionlive.com/insights/idweek-news-network-2019/idweek-2019-news-network-areas-of-improvement-for-cap-guidelines
LefamulinOmadacycline
King of Prussia firm gets first drug approval from FDAhttps://www.inquirer.com/business/fda-drug-antibiotic-approval-new-class-lefamulin-20190819.html
Lefamulin
Lefamulin Could Be Vital in the Pneumonia Fight | Drug Topicshttps://www.drugtopics.com/latest/lefamulin-could-be-vital-pneumonia-fight
Bacterial pneumoniaLefamulinMoxifloxacin
Nabriva Therapeutics Receives U.S. FDA Approval of Xenleta™ (lefamulin) to Treat Community-Acquired Bacteria Pneumonia (CABP) Nasdaq:NBRVhttps://www.globenewswire.com/news-release/2019/08/19/1903735/0/en/Nabriva-Therapeutics-Receives-U-S-FDA-Approval-of-Xenleta-lefamulin-to-Treat-Community-Acquired-Bacteria-Pneumonia-CABP.html
2019-08 FDA approves use of lefamulin to treat community-acquired pneumoniaLefamulinNabriva
Nabriva scores its first FDA nod with novel antibiotic Xenleta | FiercePharmahttps://www.fiercepharma.com/marketing/nabriva-scores-fda-nod-for-novel-antibiotic-to-treat-bacterial-pneumonia
2019-08 FDA approves use of lefamulin to treat community-acquired pneumoniaLefamulinNabriva
Nabriva’s XENLETA™ (lefamulin) for the Treatment of Community-Acquired Bacterial Pneumonia (CABP) Now Available in the U.S.https://finance.yahoo.com/news/nabriva-xenleta-lefamulin-treatment-community-110000724.html
LefamulinNabriva
One molecule’s journey from discovery to markethttps://cen.acs.org/pharmaceuticals/drug-development/One-molecules-journey-discovery-market/98/i24
LefamulinRetapamulin
Stewardship / Resistance Scan for Jul 30, 2020 | CIDRAPhttps://www.cidrap.umn.edu/news-perspective/2020/07/stewardship-resistance-scan-jul-30-2020
Covid-19 and antimicrobial resistanceLefamulin

Showing topic

Lefamulin
Intravenous antibioticsNabrivaNew and investigational antibioticsOral antibioticsPleuromutilin antibiotics

Names and synonyms

  • Lefamulin
  • Xenleta
  • XENLETA
  • BC-3781